Physician profile
Michael Wolfe
NPI 1124655824
$10,097.44
in general payments reported to CMS, 2019-2025
12 companies · $1,066 in 2025
The $1,066 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,721 · 2023: $4,049 · 2024: $3,261 · 2025: $1,066.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,910 · Travel and Lodging: $3,466.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,910.29 |
| Travel and Lodging | $3,465.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,104.77 | 2023-2025 | Prostep, Ortholoc 3di, Actishield |
| Smith+Nephew, INC. | $1,708.49 | 2022 | |
| Paragon 28, INC. | $1,370.66 | 2023 | Portfolio, Mtp, Additive Orthopedics |
| Integra Lifesciences Corporation | $981.37 | 2023-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Kerecis Limited | $468.07 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Aroa Biosurgery Incorporated | $144.14 | 2023 | |
| Medwest Associates | $120.83 | 2023 | |
| Organogenesis INC. | $77.72 | 2024-2025 | Puraply Wound Matrix, Affinity |
| Kci USA, INC. | $37.16 | 2022-2023 | V.A.C.Ulta, V.A.C. Veraflo, Prevena |
| Pinnacle, INC | $32.10 | 2023 | |
| Urgo Medical North America, LLC | $27.71 | 2024 | Urgoclean Ag |
| Mimedx Group, INC. | $24.42 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Wolfe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.